» Articles » PMID: 18582794

Predictors of Survival in COPD: More Than Just the FEV1

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2008 Aug 9
PMID 18582794
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) ranks fourth as a cause of death in the United States, behind heart disease, cancer, and stroke. Additionally, since serious co-morbidities are often present in patients with COPD, many die from other diseases such as cardiac disease or cancer. Not surprisingly, multiple factors, reflective of both respiratory disease process and the substantial co-morbidity, predict survival in the disease. As might be expected, physiologic derangements such as airflow obstruction, hypoxemia, lung hyperinflation, and exercise capacity predict survival in COPD. Anemia, cachexia and reductions in lean body mass also relate to prognosis. Perhaps less recognized is the more recent documentation that more subjective assessments, such as dyspnea and health related quality of life, are also important predictors of survival. The integration of some of the most important of these variables may provide a more comprehensive evaluation of disease severity. For example, a validated multi-dimensional disease rating that includes the body mass index (B), degree of airflow obstruction (O), dyspnea (D), and exercise capacity (E) (BODE Index) is capable of predicting COPD-related hospitalization and mortality more than its individual components.

Citing Articles

The usefulness of Charlson Comorbidity Index (CCI) scoring in predicting all-cause mortality in Outpatients with Clinical Diagnoses of COPD.

Ly K, Wakefield D, ZuWallack R J Multimorb Comorb. 2025; 15:26335565251315876.

PMID: 39877897 PMC: 11773518. DOI: 10.1177/26335565251315876.


Factors Affecting Survival in Severe and Very Severe COPD after Admission in ICUs of Tertiary Care Centers of India (FAST COPD): Study Protocol for a Multicentric Cohort Study.

Arunachala S, Devapal S, Swamy D, Greeshma M, Ul Hussain I, Siddaiah J Indian J Crit Care Med. 2024; 28(6):552-560.

PMID: 39130380 PMC: 11310678. DOI: 10.5005/jp-journals-10071-24728.


The importance of addressing physical activity and exercise intolerance in our patients with COPD.

Goldstein R, Jardim J, Nici L, Raskin J, Spruit M, ZuWallack R Breathe (Sheff). 2024; 20(2):230272.

PMID: 38873238 PMC: 11167653. DOI: 10.1183/20734735.0272-2023.


The Role of Pulmonary Function Testing in the Diagnosis and Management of COPD.

Haynes J, Kaminsky D, Ruppel G Respir Care. 2023; 68(7):889-913.

PMID: 37353330 PMC: 10289615. DOI: 10.4187/respcare.10757.


Chronic Obstructive Pulmonary Disease and Its Effect on Red Blood Cell Indices.

Tariq S, Ismail D, Thapa M, Goriparthi L, Pradeep R, Khalid K Cureus. 2023; 15(3):e36100.

PMID: 37065412 PMC: 10097512. DOI: 10.7759/cureus.36100.